Why Compare Different Designs?
A causal estimate is only as credible as the assumptions that connect the observed data to the causal effect of interest. An adjusted observational analysis may be vulnerable to an unmeasured cause of both treatment and outcome. A randomized trial avoids that particular source of confounding for treatment assignment, but may face nonadherence or limited generalizability. An instrumental-variable analysis can address some treatment-selection problems, yet relies on assumptions such as exclusion that are not needed in the same form for a randomized comparison.
Triangulation means comparing evidence from designs whose important biases and assumptions differ. The aim is not to count how many estimates point in one direction. It is to ask whether their differences make sense given what each design estimates and how each could be biased. Agreement is more informative when designs have genuinely different vulnerabilities; it is not proof that all their assumptions hold.
Map the Assumptions Before Comparing Estimates
An observational analysis commonly compares outcomes under treatment \(D=1\) and no treatment \(D=0\), adjusting for measured covariates \(X\). For a causal interpretation, the measured covariates must suffice to control confounding: conditional on \(X\), treatment must be independent of the relevant potential outcomes. Consistency requires that each person’s observed outcome under the treatment received equal the corresponding potential outcome; positivity requires that each treatment option have a positive probability at covariate levels represented in the target population. If an unmeasured variable \(U\) affects both treatment and outcome, conditional exchangeability may fail even after adjustment for \(X\).
Random assignment makes treatment assignment independent of potential outcomes, on average, in the randomized population. Thus, a comparison by assigned group identifies the intention-to-treat effect under standard conditions such as consistent outcome measurement and appropriate handling of missing outcomes. When people do not adhere to assigned treatment, that effect is the effect of assignment, not automatically the effect of receiving treatment. Randomization also does not guarantee that the trial population represents every population to which one might wish to generalize.
An instrumental-variable analysis uses an instrument \(Z\) that shifts treatment uptake \(D\). For the usual Wald ratio to identify a complier average treatment effect, the instrument must be relevant, independent of the joint vector of potential outcomes and potential treatment statuses, satisfy exclusion, and satisfy monotonicity. Relevance means assignment to different instrument levels changes treatment uptake. Independence means \(Z\) is independent of \((Y(0),Y(1),D(0),D(1))\), where \(D(z)\) is the treatment status under instrument level \(z\). Exclusion means \(Z\) affects the outcome only through treatment. Monotonicity means the instrument does not cause anyone to move opposite to its treatment-encouraging direction. The resulting effect is for compliers, not necessarily the average treatment effect in the full population.
Negative-control outcomes and exposures can reveal patterns that raise concern about hidden bias, but a negative-control association is not itself a direct estimate of the causal effect under study. Its diagnostic value depends on whether it shares relevant causes or measurement processes with the primary analysis and on whether the control is truly unaffected by the treatment or exposure of interest.
Bias Direction Depends on the Causal Structure
The direction of confounding is not determined by the word “unmeasured.” It depends on how the omitted variable relates to treatment and outcome, and on the chosen effect scale. For example, on an additive outcome scale, suppose the conditional mean follows the simplified model \(E[Y\mid D,U]=\beta_0+\tau D+\gamma U\), with no other confounding and no interaction. Here \(\tau\) is the treatment effect and \(\gamma\) is the outcome difference associated with \(U\). Let \(q_d=P(U=1\mid D=d)\). The unadjusted treated-minus-untreated contrast is then
The second term is the confounding bias in this simplified model. If \(U\) increases the outcome (\(\gamma>0\)) and is more common among treated people (\(q_1>q_0\)), the bias is positive. For a beneficial treatment whose effect is negative on this scale, this positive bias makes the observed effect look less beneficial than the causal effect. If the treated group has less of the harmful \(U\), the bias instead points in the negative direction and can exaggerate apparent benefit. This sign argument is specific to the stated additive model; interactions or another outcome scale can change it.
Worked Example: Predicting the Direction of Confounding
Hypothetical data-generating scenario. A treatment is intended to reduce hospital admissions. Let \(Y\) be admissions per 1,000 patients, and let \(U=1\) indicate severe underlying illness. Suppose the treatment has a constant causal effect of \(\tau=-4\) admissions per 1,000, severe illness is associated with \(\gamma=+10\) admissions per 1,000, and \(U\) occurs in 60% of treated patients and 30% of untreated patients. Assume the simplified additive model above applies.
The omitted-variable bias is
Therefore, the unadjusted contrast is \(\tau+B=-4+3=-1\) admission per 1,000. It understates the treatment’s benefit in this scenario: severe illness both raises admissions and is more common among treated patients. The calculation describes a hypothetical mechanism, not evidence that this bias occurred in any particular study.
Worked Comparisons Across Designs
Worked Example: A Randomized Encouragement as an Instrument
Hypothetical data. In a randomized encouragement study, \(Z=1\) denotes assignment to encouragement and \(Z=0\) denotes no encouragement. Treatment uptake is 0.50 for \(Z=1\) and 0.30 for \(Z=0\). Mean admissions are 17 per 1,000 for \(Z=1\) and 18 per 1,000 for \(Z=0\). Assume relevance, exclusion, monotonicity, and independence of \(Z\) from the joint vector \((Y(0),Y(1),D(0),D(1))\). Random assignment can provide that independence. Also assume consistency and that the outcome and treatment are measured as specified.
The assignment effect on the outcome is \(17-18=-1\) admission per 1,000, while its effect on treatment uptake is \(0.50-0.30=0.20\). The Wald ratio is
Under the stated assumptions, this ratio identifies the average treatment effect among compliers: people whose treatment status is changed by the encouragement. The independence assumption must cover potential treatment statuses as well as potential outcomes. Independence from potential outcomes alone would not rule out an association between \(Z\) and who would take treatment. The estimate is not automatically the effect for all patients, and the arithmetic alone does not establish the assumptions.
Worked Example: Comparing an Observational Estimate With a Sensitivity Range
Hypothetical comparison. An observational analysis reports an adjusted effect of \(-4.0\) admissions per 1,000 patients. The target is the average treatment effect in a specified population and follow-up period. Investigators judge that residual confounding could plausibly contribute a bias \(B\) between \(-1.5\) and \(+2.5\) admissions per 1,000, using the convention \(\text{observed estimate}=\text{causal effect}+B\). The range is a sensitivity assumption, not a value directly observed in the data.
Subtracting each possible bias from the estimate gives the implied range for the causal effect:
Thus the sensitivity range is \([-6.5,-2.5]\) admissions per 1,000. Suppose, separately, a randomized trial targeting the same population, treatment, outcome scale, and follow-up reports \(-2.2\), with a 95% confidence interval from \(-3.4\) to \(-1.0\) admissions per 1,000. The trial interval overlaps the observational sensitivity range from \(-3.4\) to \(-2.5\). That overlap indicates compatibility under the stated uncertainty and sensitivity assumptions; it does not prove that either estimate is unbiased. The confidence interval describes sampling uncertainty under the trial’s analysis, whereas the sensitivity range describes the consequences of assumed residual-bias values.
If an instrumental-variable estimate were also available, its target might be the complier effect rather than the population average effect. It should not be treated as a third estimate of the same quantity unless the target populations and effects are justified as comparable. A discrepancy could reflect bias, sampling variation, different estimands, or a violated assumption.
Worked Example: Interpreting a Negative-Control Signal
Hypothetical diagnostic. An observational study estimates the effect of a new medication on hospital admissions. The researchers also examine a negative-control outcome that the medication is not expected to affect, but that may share causes of treatment selection and outcome recording. The medication group has a 6-percentage-point higher rate of this control outcome after the same covariate adjustment.
The 6-percentage-point difference is an association for the control outcome, not an estimate of the medication’s effect on admissions. If the control is valid and its shared causes are relevant, the nonzero association signals that residual structure, such as unmeasured confounding or selection, may remain. It does not by itself show that the primary estimate is biased upward by exactly 6 percentage points: the outcomes may respond differently to shared causes, and the control association may have other explanations. The diagnostic should prompt scrutiny of the causal assumptions and comparison with evidence from designs vulnerable to different biases.
How to Triangulate Without Overclaiming
A disciplined comparison begins by writing down what each estimate represents and what could distort it. The following sequence keeps the comparison focused on causal structure rather than on whether point estimates happen to agree.
Specify the population, treatment contrast, outcome, follow-up, and effect scale for every estimate. Mark estimates that target a different quantity, such as an assignment effect or a complier effect.
For each design, state the assumptions needed to interpret its estimate causally. Distinguish assumptions supported by design features, such as randomized assignment, from assumptions that cannot be verified directly from the observed data.
Ask what unmeasured factors, selection processes, nonadherence, or direct pathways could affect each estimate. Where a direction can be justified, state the mechanism and scale behind it; do not assign a direction merely because confounding is possible.
Consider sampling uncertainty alongside sensitivity analyses and design-specific diagnostics. Agreement is more persuasive when the estimates are meaningfully comparable and the leading bias mechanisms differ; disagreement is a prompt to investigate, not a vote against causality.
Why the Distinctions Matter
Triangulation is useful because no single design is automatically decisive. Observational adjustment may control rich measured covariates while leaving hidden confounding. Randomization protects the assignment comparison from baseline confounding, but nonadherence changes what that comparison estimates. An instrument can address treatment selection under its assumptions, but an invalid exclusion restriction can undermine its interpretation. Negative controls can expose warning signs, but they do not repair a primary analysis by themselves.
A common mistake is to call several estimates “independent confirmation” simply because they come from different analyses. If they share the same unmeasured cause, outcome measurement problem, or selection mechanism, their errors may also be shared. Another mistake is to average estimates with different targets, such as a population average effect and a complier effect. The correction is to map each design’s assumptions and vulnerabilities first, check whether the estimands are comparable, and then judge whether the pattern of results is coherent under plausible bias scenarios.
Check Your Understanding
Use the assumptions and bias logic in this tutorial to answer the questions.
- In the additive model, if \(U\) increases the outcome and is more common among treated people, what is the direction of bias in the treated-minus-untreated contrast?
- Why must an instrument’s independence assumption cover potential treatment statuses as well as potential outcomes for the usual Wald-ratio interpretation?
- A randomized trial has substantial nonadherence. What effect does a comparison by randomized assignment target, and why is that not automatically the effect of treatment received?
- An observational sensitivity analysis gives a bias range, while a trial reports a confidence interval. What distinct uncertainties do these summaries represent?
- Why might an instrumental-variable estimate and an observational population-average estimate differ even if both analyses are valid?